Resistance of subtype C HIV-1 strains to anti-V3 loop antibodies

Advances in Virology

Volumn 2012, Issue , 2012, Pages

  Almond, David ^a   Krachmarov, Chavdar ^b   Swetnam, James ^a   Zolla Pazner, Susan ^a   Cardozo, Timothy ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84871670176     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2012/803535     Document Type: Article

References (28)

1. Ariën K. K., Vanham G., Arts E. J., Is HIV-1 evolving to a less virulent form in humans? Nature Reviews Microbiology 2007 5 2 141 151 2-s2.0-33846502673 10.1038/nrmicro1594 (Pubitemid 46151872)
2. Ball S. C., Abraha A., Collins K. R., Marozsan A. J., Baird H., Quiñones-Mateu M. E., Penn-Nicholson A., Murray M., Richard N., Lobritz M., Zimmerman P. A., Kawamura T., Blauvelt A., Arts E. J., Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C. Journal of Virology 2003 77 2 1021 1038 2-s2.0-0037223706 10.1128/JVI.77.2.1021-1038.2003 (Pubitemid 36055524)
3. Rusche J. R., Javaherian K., McDanal C., Petro J., Lynn D. L., Grimaila R., Langlois A., Gallo R. C., Arthur L. O., Fischinger P. J., Bolognesi D. P., Putney S. D., Matthews T. J., Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proceedings of the National Academy of Sciences of the United States of America 1988 85 9 3198 3202 2-s2.0-0041914944
4. Palker T. J., Clark M. E., Langlois A. J., Matthews T. J., Weinhold K. J., Randall R. R., Bolognesi D. P., Haynes B. F., Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proceedings of the National Academy of Sciences of the United States of America 1988 85 6 1932 1936 2-s2.0-0024121522 10.1073/pnas.85.6.1932 (Pubitemid 24315798)
5. Goudsmit J., Debouck C., Meloen R. H., Smit L., Bakker M., Asher D. M., Wolff A. V., Gibbs C. J., Carleton Gajdusek D., Human immunodeficiency virus type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proceedings of the National Academy of Sciences of the United States of America 1988 85 12 4478 4482 2-s2.0-0043080631
6. Huang C. C., Tang M., Zhang M. Y., Majeed S., Montabana E., Stanfield R. L., Dimitrov D. S., Korber B., Sodroski J., Wilson I. A., Wyatt R., Kwong P. D., Structural biology: structure of a V3-containing HIV-1 gp120 core. Science 2005 310 5750 1025 1028 2-s2.0-27744597054 10.1126/science.1118398 (Pubitemid 41611916)
7. Patel M. B., Hoffman N. G., Swanstrom R., Subtype-specific conformational differences within the V3 region of subtype B and subtype C human immunodeficiency virus type 1 Env proteins. Journal of Virology 2008 82 2 903 916 2-s2.0-37849007568 10.1128/JVI.01444-07
8. Xiao L., Owen S. M., Goldman I., Lal A. A., Dejong J. J., Goudsmit J., Lal R. B., CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. Virology 1998 240 1 83 92 2-s2.0-0032484486 10.1006/viro.1997.8924 (Pubitemid 28394126)
9. Shioda T., Levy J. A., Cheng-Mayer C., Macrophage and T cell-line tropisms of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature 1991 349 6305 167 169 2-s2.0-0026089184 10.1038/349167a0 (Pubitemid 21912038)
10. Hwang S. S., Boyle T. J., Lyerly H. K., Cullen B. R., Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 1991 253 5015 71 74 2-s2.0-0025783669 (Pubitemid 21917121)
11. Fouchier R. A. M., Groenink M., Kootstra N. A., Tersmette M., Huisman H. G., Miedema F., Schuitemaker H., Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. Journal of Virology 1992 66 5 3183 3187 2-s2.0-0026606727
12. De Jong J. J., De Ronde A., Keulen W., Tersmette M., Goudsmit J., Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: analysis by single amino acid substitution. Journal of Virology 1992 66 11 6777 6780 2-s2.0-0026702003
13. De Jong J., Simon F., Van Der Groen G., Baan E., Saragosti S., Brun-Vézinet F., Goudsmit J., V3 loop sequence analysis of seven HIV type 1 group O isolates phenotyped in peripheral blood mononuclear cells and MT-2 cells. AIDS Research and Human Retroviruses 1996 12 16 1503 1507 2-s2.0-0029910803 (Pubitemid 26366908)
14. Cardozo T., cardot01@nyumc.org Swetnam J., Pinter A., Krachmarov C., Nadas A., Almond D., Zolla-Pazner S., Worldwide distribution of HIV type 1 epitopes recognized by human anti-V3 monoclonal antibodies. AIDS Research and Human Retroviruses 2009 25 4 441 450 10.1089/aid.2008.0188
15. Stanfield R. L., Gorny M. K., Zolla-Pazner S., Wilson I. A., Crystal structures of human immunodeficiency virus type 1 (HIV-1) neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity. Journal of Virology 2006 80 12 6093 6105 2-s2.0-33744933182 10.1128/JVI.00205-06 (Pubitemid 43849187)
16. Stanfield R. L., Gorny M. K., Williams C., Zolla-Pazner S., Wilson I. A., Structural Rationale for the Broad Neutralization of HIV-1 by Human Monoclonal Antibody 447-52D. Structure 2004 12 2 193 204 2-s2.0-1242351232 10.1016/S0969-2126(04)00005-X (Pubitemid 38224543)
17. Krachmarov C. P., Honnen W. J., Kayman S. C., Gorny M. K., Zolla-Pazner S., Pinter A., Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. Journal of Virology 2006 80 14 7127 7135 2-s2.0-33745796735 10.1128/JVI.02619-05 (Pubitemid 44025209)
18. Almond D., Dynamic characterization of the V3 loop crown. Antiviral Therapy 2007 12 supplement 2 P13 P31
19. Verma A., Wenzel W., Conformational landscape of the HIV-V3 hairpin loop from all-atom free-energy simulations. Journal of Chemical Physics 2008 128 10 6 2-s2.0-40849094511 10.1063/1.2844788 105103 (Pubitemid 351399745)
20. Almond D., Kimura T., Kong X., Swetnam J., Zolla-Pazner S., Cardozo T., Structural conservation predominates over sequence variability in the crown of HIV type 1's V3 loop. AIDS Research and Human Retroviruses 2010 26 6 717 723 2-s2.0-77954191991 10.1089/aid.2009.0254
21. Abagyan R., Totrov M., Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. Journal of Molecular Biology 1994 235 3 983 1002 2-s2.0-0027955787 10.1006/jmbi.1994.1052 (Pubitemid 24047836)
22. Totrov M., Abagyan R., Rapid boundary element solvation electrostatics calculations in folding simulations: successful folding of a 23-residue peptide. Biopolymers 2001 60 2 124 133 2-s2.0-0034863617 10.1002/1097-0282(2001)60: 2<124::AID-BIP1008>3.0.CO;2-S (Pubitemid 32743529)
23. Krachmarov C. P., Kayman S. C., Honnen W. J., Trochev O., Pinter A., V3-specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1. AIDS Research and Human Retroviruses 2001 17 18 1737 1748 2-s2.0-0035701793 10.1089/08892220152741432 (Pubitemid 34114211)
24. Connor R. I., Chen B. K., Choe S., Landau N. R., Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995 206 2 935 944 2-s2.0-0028842207 10.1006/viro.1995.1016
25. Sharon M., Kessler N., Levy R., Zolla-Pazner S., Görlach M., Anglister J., Alternative conformations of HIV-1 V3 loops mimic β hairpins in chemokines, suggesting a mechanism for coreceptor selectivity. Structure 2003 11 2 225 236 2-s2.0-0037317611 10.1016/S0969-2126(03)00011-X (Pubitemid 36183646)
26. Gaschen B., Taylor J., Yusim K., Foley B., Gao F., Lang D., Novitsky V., Haynes B., Hahn B. H., Bhattacharya T., Korber B., Diversity considerations in HIV-1 vaccine selection. Science 2002 296 5577 2354 2360 2-s2.0-0037189323 10.1126/science.1070441 (Pubitemid 34734202)
27. Zolla-Pazner S., Zhong P., Revesz K., Volsky B., Williams C., Nyambi P., Gorny M. K., The cross-clade neutralizing activity of a human monoclonal antibody is determined by the GPGR V3 motif of HIV type 1. AIDS Research and Human Retroviruses 2004 20 11 1254 1258 2-s2.0-9344246864 10.1089/aid.2004.20. 1254 (Pubitemid 39557875)
28. Haynes B. F., Case control study of the RV144 trial for immune correlates: the analysis and way forward. AIDS Vaccine 2011 Bangkok, Thailand Mary Ann Leibert